Visual inspection: during the investigation, scratches and organic deposits on the outer housing of the valves, but no significant deformations or damage were determined.Permeability test: a permeability test has shown that all components are permeable.Computer controlled test: to investigate the opening pressure of the valves, they were tested with a miethke computer controlled testing apparatus which simulates a cerebrospinal fluid flow.The valves are tested in both the horizontal as well as the vertical positions.The results show that the progav 2.0 operates within the accepted tolerance in the horizontal position.The shuntassistant does not operate within the specified tolerances in the vertical position.An accelerated outflow of shuntassistant could be determined.Adjustment test: the progav 2.0 was tested and is adjustable to all specified pressures.Braking force and brake function test: the brake functionality test has shown that the brake function operates as expected and the braking force is within the given tolerances.Internal inspection: after dismantling of the valves, deposits were found in both valves.To make the deposits in the shunt system more visible, they were colored using a staining solution.Results: based on our investigation results, we can determine visible deposits in the progav 2.0.The deposits visible in the valve had no effect upon the specifications at the time of the examination.The adjustment difficulties complained about could not be confirmed.Based on our test results, we can determine an accelerated outflow at the shuntassistant.The deposits visible in the valve may have led to the change in flow rate.Deposits caused by substances naturally present in the patient's body, such as protein, blood or tissue particles, are among the known and unavoidable risks and side effects of hydrocephalus therapy.Even small amounts of organic material can affect the integrity of the valve.The cathters and the sprung reservoir met the specification.We can exclude a defect at the time of release.The shunt system met all specifications of the final inspection when released from christoph miethke gmbh & co.Kg.No further regulatory actions are required from our point of view.
|
It was reported that a progav 2.0 shunt system (#fx428t) was implanted during a procedure performed on (b)(6) 2015.According to the complainant, the shunt system showed adjustment difficulties.The patient underwent a revision procedure performed on (b)(6) 2024.The complainant device has returned to the manufacturer for evaluation.No patient complications were reported as a result of the revision procedure.Age: 41 years, 5 months.Weight: 94 kgs.Height: 173 cm.Gender: female.
|